Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Rimegepant For Cgrp Related DisordersPFIZERMay 28, 2026BARDEHLE PAGENBERG
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 20, 2026SANDOZ
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 19, 2026HGF
Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function DiseasesNUTRICIAMay 19, 2026SOCIT DES PRODUITS NESTL
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 13, 2026DEVA HOLDING
Nanocapsules Comprising A Liposoluble Active Ingredient, Production And UsesADISSEO FRANCEMay 12, 2026DSM NUTRITIONAL PRODUCTS
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 12, 2026HAMM & WITTKOPP
Ophthalmic Composition Based On Hyaluronic Acid To Protect From Damages Caused By Environmental PollutionCOLOMBOMay 12, 2026MAIWALD
Cationic Lipids For Use In Lipid NanoparticlesACUITAS THERAPEUTICSMay 12, 2026GENZYME
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 10, 2026SYNTHON

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Jan 7, 2026Formulations Of EnzalutamideASTELLAS PHARMA14
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS11
Aug 20, 2025Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPE11
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10